Form 4: Septerna CEO Jeffrey Finer Increases Stake in Company
SEC Form 4 Filing
Septerna's CEO, Jeffrey Finer, has recently acquired additional shares of the company's common stock through a series of transactions.
Summary
- Jeffrey Finer, the CEO and President of Septerna, Inc., has increased his holdings in the company's common stock.
- On February 25, 2025, he purchased 10,000 shares at a weighted average price of $5.6765, with prices ranging from $5.55 to $5.74.
- He further acquired 4,000 shares on February 26, 2025, at a weighted average price of $5.6989, with prices ranging from $5.695 to $5.71.
- Finally, on February 27, 2025, he purchased 3,000 shares at a price of $5.8.
- Following these transactions, Finer directly owns 771,907 shares of Septerna's common stock.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The CEO's stock purchases suggest confidence in the company, but it's a routine transaction.
Positives
- The CEO's increased investment in the company may signal confidence in Septerna's future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company's leadership believes the stock is undervalued.
Stakeholder Impact
- Shareholders may view the CEO's stock purchases as a positive signal.
Key Dates
| Date | Description |
|---|---|
| 02/25/2025 | CEO purchased 10,000 shares of common stock at a weighted average price of $5.6765. |
| 02/26/2025 | CEO purchased 4,000 shares of common stock at a weighted average price of $5.6989. |
| 02/27/2025 | CEO purchased 3,000 shares of common stock at a price of $5.8. |
| 02/27/2025 | Date of the form filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.